The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113
By A Mystery Man Writer
Description
Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
Cannabinoid-1 receptor inverse agonists: current understanding of mechanism of action and unanswered questions
Medicina, Free Full-Text
APExBIO - AM4113, cannabinoid receptor 1 (CB1)-selective neutral antagonist
A neutral CB1 receptor antagonist reduces weight gain in rat American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
Identification of a Potent and Selective Cannabinoid CB1 Receptor
Effects of pretreatment with the selective cannabinoid CB1-receptor
Full article: A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents
Medicina, Free Full-Text
Molecules, Free Full-Text
Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC
The endocannabinoid system – current implications for drug development - Fowler - 2021 - Journal of Internal Medicine - Wiley Online Library
Summary of the functional differences between cannabinoid CB1 and CB2
PDF) Targeting the Endocannabinoid CB1 Receptor to Treat Body
DDC, Free Full-Text
from
per adult (price varies by group size)